Reviewed by PillSeek Editorial Team · Last updated
About This Medication
This medication is a White Capsule 19 mm, Tablet with imprint "Y213". It contains Acyclovir 800 mg; of Acyclovir[acyclovir];. This belongs to the Herpesvirus nucleoside analog dna polymerase inhibitor pharmacologic class. It is manufactured by NuCare Pharmaceuticals,Inc.. For details please contact your physician.
Basic Information
- Imprint
- Y213
- Color
- White
- Shape
- Capsule
- Size
- 19 mm
Drug Information
- Strength
- Acyclovir 800 mg;
- Dosage Form
- Tablet
- RxCUI
- 197313
Pharmaceutical Classification
- Pharmacologic Class
- Herpesvirus nucleoside analog dna polymerase inhibitor
Related Medications
Other drugs in the same class: Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor
- acyclovirACYCLOVIR 400 mg;WHITE • OVAL
- acyclovirACYCLOVIR 800 mg;WHITE • OVAL
- AcyclovirACYCLOVIR 200 mg;BLUE • CAPSULE
- AcyclovirACYCLOVIR 200 mg;LACTOSE MONOHYDRATE 195.5 mg;SODIUM STARCH GLYCOLATE TYPE A POTATO 21.15 mg;SODIUM LAURETH SULFATE 2.12 mg;MAGNESIUM STEARATE 4.23 mg;BLUE • CAPSULE
- AcyclovirAcyclovir 200 mg;Lactose Monohydrate 195.5 mg;Sodium Starch Glycolate Type A Potato 21.15 mg;Sodium Lauryl Sulfate 2.12 mg;Magnesium Stearate 4.23 mg;BLUE • OVAL
- AcyclovirACYCLOVIR 400.00 mg;WHITE • CAPSULE
- AcyclovirACYCLOVIR 400 mg;WHITE • CAPSULE
- AcyclovirACYCLOVIR 800.00 mg;WHITE • CAPSULE
- AcyclovirAcyclovir 800 mg;WHITE • OVAL
- AcyclovirACYCLOVIR 800 mg;WHITE • OVAL
Ingredients
- Active Ingredients
- Acyclovir[acyclovir];
- Inactive Ingredients
- Microcrystalline cellulose;sodium starch glycolate type a potato;povidone k30;magnesium stearate;
Additional Information
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Status (Rx/OTC)
- Rx
- Brand Names
- Sitavig, Xerese, Zovirax
Browse Related Pills
⚠️ Important: This information is for educational purposes only. Do not use this tool for medical diagnosis or treatment decisions. Always consult your pharmacist or healthcare provider for questions about your medications. Read full medical disclaimer.